Literature DB >> 8787430

Alteration of lung diffusion capacity in IgA nephropathy.

S Ravilly1, M Chaussain, J L Iniguez, A Lenhert, G Kalifa, P Brun, P Niaudet, D Gendrel.   

Abstract

OBJECTIVE: To establish whether changes of lung transfer for carbon monoxide (TLCO) are related to the phase of IgA nephropathy.
METHODS: Respiratory function was tested in 12 children with IgA nephropathy assessed by percutaneous renal biopsy. This was done during acute exacerbations or haematuria-free phases of the disease.
RESULTS: TLCO was low in 12/13 measurements made in the haematuric phase of IgA nephropathy or during the month following gross haematuria (mean TLCO 64% of expected values). Lung volumes and blood gas values were normal and only minor radiological signs of interstial lung involvement were observed in 11/12 patients. When respiratory tests were performed more than three months after gross haematuria, TLCO was low in 4/9 patients, with no relation to the significance of residual proteinuria or severity of findings at renal biopsy. There was a significant difference between tests performed when haematuria was present or recent and those performed more than three months after an episode of gross haematuria (p < 0.01).
CONCLUSIONS: The decrease of TLCO in the acute phases of the disease is probably related to alterations of the lung alveolarcapillary membrane by immune complexes containing IgA. This non-invasive technique, easy to perform and repeat, could be of value in the diagnosis of IgA nephropathy in haematuric children.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8787430      PMCID: PMC1511411          DOI: 10.1136/adc.74.3.236

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  11 in total

1.  Lung function in interstitial lung diseases in children.

Authors:  C Gaultier; M Chaussain; M Boulé; A Buvry; Y Allaire; L Perret; F Girard
Journal:  Bull Eur Physiopathol Respir       Date:  1980 Jan-Feb

2.  Berger disease: Henoch-Schönlein syndrome without the rash.

Authors:  S R Meadow; D G Scott
Journal:  J Pediatr       Date:  1985-01       Impact factor: 4.406

3.  Impairment of lung diffusion capacity in Schönlein-Henoch purpura.

Authors:  M Chaussain; D de Boissieu; G Kalifa; S Epelbaum; P Niaudet; J Badoual; D Gendrel
Journal:  J Pediatr       Date:  1992-07       Impact factor: 4.406

4.  Serum IgA-fibronectin aggregates in patients with IgA nephropathy and Henoch-Schönlein purpura: diagnostic value and pathogenic implications. The Glomerular Disease Collaborative Network.

Authors:  J C Jennette; J Wieslander; R Tuttle; R J Falk
Journal:  Am J Kidney Dis       Date:  1991-10       Impact factor: 8.860

5.  Circulating IgA-immune complexes in Henoch-Schönlein purpura. A longitudinal study of their relationship to disease activity and vascular deposition of IgA.

Authors:  R H Kauffmann; W A Herrmann; C J Meÿer; M R Daha; L A Van Es
Journal:  Am J Med       Date:  1980-12       Impact factor: 4.965

6.  Mesangial cell autoantigens in immunoglobulin A nephropathy and Henoch-Schönlein purpura.

Authors:  D J O'Donoghue; A Darvill; F W Ballardie
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

7.  Vascular IgA deposits in clinically normal skin of patients with renal disease.

Authors:  A J Thompson; Y L Chan; A J Woodroffe; A R Clarkson; A E Seymour
Journal:  Pathology       Date:  1980-07       Impact factor: 5.306

8.  Course and long-term outcome of idiopathic IgA nephropathy in children.

Authors:  T Linné; U Berg; S O Bohman; L Sigström
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

9.  Lung transfer factor for CO at rest in normal children by a steady-state method.

Authors:  M Chaussain; A Denjean; C Lebeau; J De Lattre; J Badoual
Journal:  Bull Eur Physiopathol Respir       Date:  1982 May-Jun

10.  Lymphocyte subpopulations and function in childhood IgA nephropathy.

Authors:  A Kameda; N Yoshikawa; S Shiozawa; K Doi; H Nakamura
Journal:  Nephron       Date:  1991       Impact factor: 2.847

View more
  1 in total

1.  No impairment of pulmonary function in children with Henoch-Schonlein purpura after 4-year follow-up.

Authors:  Izabela Grabska-Kobylecka; Dariusz Nowak; Anna Wlodarczyk; Piotr Bialasiewicz
Journal:  Clin Rheumatol       Date:  2016-07-27       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.